AMRX
Amneal Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$17.44
−2.41%0
Insider buys (3m)
4
Insider sells (3m)
-$7.2M
Net value (3m)
+28.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 14, 2026 | Kiely John · director | Sale | 50,000 | $18 |
| Aug 13, 2026 | Daly Jason B. · officer: EVP, Chief Legal Officer | Sale | 6,613 | $18 |
| Aug 13, 2026 | Shah Nikita · officer: Executive Vice President | Sale | 146,403 | $18 |
| Aug 13, 2026 | BUCHI J KEVIN · director | M-Exempt | 168,573 | $17 |
| Aug 13, 2026 | Daly Jason B. · officer: EVP, Chief Legal Officer | Sale | 210,000 | $17 |
| Aug 12, 2026 | Patel Tushar Bhikhubhai · 10 percent owner | A-Award | 12,763,469 | $375.0M |
| Aug 12, 2026 | Patel Gautam · director | A-Award | 283,632 | $375.0M |
| Aug 12, 2026 | Patel Chirag K. · director, officer: President & Co-CEO | A-Award | 6,381,734 | $375.0M |
| Aug 12, 2026 | Patel Chintu · director, officer: Co-CEO | A-Award | 6,381,734 | $375.0M |
| May 12, 2026 | Autor Deborah M. · director | Sale | 34,819 | $13 |
| May 8, 2026 | Kiely John · director | M-Exempt | 34,819 | $0.00 |
| May 8, 2026 | Autor Deborah M. · director | A-Award | 19,824 | $0.00 |
| May 8, 2026 | Nark Ted C · director | M-Exempt | 34,819 | $0.00 |
| May 8, 2026 | BUCHI J KEVIN · director | M-Exempt | 34,819 | $0.00 |
| May 8, 2026 | George Jeffrey P. · director | A-Award | 19,824 | $0.00 |
| May 8, 2026 | Yanai Shlomo · director | M-Exempt | 34,819 | $0.00 |
| May 8, 2026 | George Jeffrey P. · director | M-Exempt | 34,819 | $0.00 |
| May 8, 2026 | Yanai Shlomo · director | A-Award | 19,824 | $0.00 |
| May 8, 2026 | Autor Deborah M. · director | M-Exempt | 34,819 | $0.00 |
| May 8, 2026 | Kiely John · director | A-Award | 19,824 | $0.00 |
| May 8, 2026 | BUCHI J KEVIN · director | A-Award | 19,824 | $0.00 |
| May 8, 2026 | Nark Ted C · director | A-Award | 19,824 | $0.00 |
| May 8, 2026 | MEISTER PAUL M · director | A-Award | 30,837 | $0.00 |
| May 8, 2026 | Patel Gautam · director | A-Award | 19,824 | $0.00 |
| May 8, 2026 | Patel Gautam · director | M-Exempt | 34,819 | $0.00 |
| May 8, 2026 | MEISTER PAUL M · director | M-Exempt | 48,747 | $0.00 |
| Mar 27, 2026 | Patel Chirag K. · director, officer: President & Co-CEO | A-Award | 544,663 | $0.00 |
| Mar 27, 2026 | Patel Chintu · director, officer: Co-CEO | A-Award | 544,663 | $0.00 |
| Mar 5, 2026 | Daly Jason B. · officer: EVP, Chief Legal Officer | M-Exempt | 22,645 | $0.00 |
| Mar 5, 2026 | Patel Chintu · director, officer: Co-CEO | F-InKind | 17,112 | $13 |
Institutional positioning
13F filings over the trailing two quarters
New 130Increased 254Reduced 166Sold out 54
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 26,562,093 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 24,519,192 | May 13, 2026 |
| TPG GP A, LLC | Unchanged | 12,328,767 | May 15, 2026 |
| TPG GP A, LLC | Unchanged | 12,328,767 | Aug 14, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 12,137,727 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 11,324,933 | May 8, 2026 |
| RUBRIC CAPITAL MANAGEMENT LP | Reduced | 11,037,589 | May 15, 2026 |
| Rubric Capital Management LP | Reduced | 10,168,660 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 7,710,126 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 7,585,034 | May 15, 2026 |
| STATE STREET CORP | Increased | 7,356,977 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 6,794,702 | May 15, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 5,794,263 | Aug 11, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 5,690,586 | May 7, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 5,139,449 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 14, 2026